Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Biol Chem. 2005 Jul 22;280(29):26770-5. Epub 2005 May 20.

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.

Author information

  • 1Division of Neuroscience, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mikhail.semenov@childrens.harvard.edu

Abstract

Sclerosteosis is an autosomal recessive disease that is characterized by overgrowth of bone tissue and is linked to mutations in the gene encoding the secreted protein SOST. Sclerosteosis shares remarkable similarities with "high bone mass" diseases caused by "gain-of-function" mutations in the LRP5 gene, which encodes a coreceptor for Wnt signaling proteins. We show here that SOST antagonizes Wnt signaling in Xenopus embryos and mammalian cells by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation. Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients.

PMID:
15908424
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk